Trevena (TRVN) to Offer Common Stock

Go back to Trevena (TRVN) to Offer Common Stock

Trevena Announces Proposed Public Offering of Common Stock

August 11, 2020 4:01 PM UTC

CHESTERBROOK, Pa., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical company focused on the development and commercialization of novel medicines for patients with central nervous system (CNS) disorders, announced today that it intends to offer and sell shares of its common stock in an underwritten public offering. In addition, Trevena intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the public offering. The offering is subject to market conditions, and... More